Trial
NCT02430532
BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Biogen
Collaborators
—
Condition
Multiple Sclerosis, Secondary Progressive
Intervention
dimethyl fumarate
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-26